Hans Leemhuis

Hans Leemhuis

Auto-generated profile, based on publicly available information

Hans Leemhuis

Royal Avebe, Avebe Innovation Center, Zernikelaan 8, 9747 AA Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2004 in Biochemistry
Verified
Journal Article
Open access
HLHans Leemhuis
Hans Leemhuis
UWUdo F. Wehmeier
Udo F. Wehmeier
LDLubbert Dijkhuizen
Lubbert Dijkhuizen
Acarviosyl transferase (ATase) from Actinoplanes sp. SE50/110 is a bacterial enzyme that transfers the acarviosyl moiety of the diabetic drug acarbose to sugar acceptors. The enzyme exhibits 42% sequence identity with cyclodextrin glycosyltransferases (CGTase), and both enzymes are members of the α-amylase family, a large clan of enzymes acting on starch and related compounds. ATase is virtually inactive on starch, however. In contrast, ATase is the only known enzyme to efficiently use acarbose as substrate (2 μmol min-1 mg-1); acarbose is a strong inhibitor of CGTase and of most other α-amylase family enzymes. This distinct reaction specificity makes ATase an interesting enzyme to investigate the variation in reaction specificity of α-amylase family enzymes. Here we show that a G140H mutation in ATase, introducing the typical His of the conserved sequence region I of the α-amylase family, changed ATase into an enzyme with 4-α-glucanotransferase activity (3.4 μmol min-1 mg-1). Moreover, this mutation introduced cyclodextrin-forming activity into ATase, converting 2% of starch into cyclodextrins. The opposite experiment, removing this typical His side chain in CGTase (H140A), introduced acarviosyl transferase activity in CGTase (0.25 μmol min-1 mg-1).

24 August 2021 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
EPEvelien M. Te Poele
Evelien M. Te Poele
SHStevan E. van der Hoek
Stevan E. van der Hoek
CCChrysovalantou Anastasia Chatziioannou
Chrysovalantou Anastasia Chatziioannou
GGGerrit J. Gerwig
Gerrit J. Gerwig
WDWouter J. Duisterwinkel
Wouter J. Duisterwinkel
HLHans Leemhuis
Hans Leemhuis

9 November 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
ALAlexia Lepine
Alexia Lepine
RHRoderick Harold Jan de Hilster
Roderick Harold Jan de Hilster
HLHans Leemhuis
Hans Leemhuis
LOLizette Oudhuis
Lizette Oudhuis
PBPiet L. Buwalda
Piet L. Buwalda
Paul De VosPaul De Vos
Paul De Vos
Scope: Resistant starches (RSs) are classically considered to elicit health benefits through fermentation. However, it is recently shown that RSs can also support health by direct immune interactions. Therefore, it has been hypothesized that the structural traits of RSs might impact the health benefits associated with their consumption.Methods and results: Effects of crystallinity, molecular weight, and chain length distribution of RSs are determined on immune Toll‐like receptors (TLRs), dendritic cells (DCs), and T‐cell cytokines production. To this end, four type‐3 RSs (RS3) are compared, namely Paselli WFR, JD150, debranched Etenia, and Amylose fraction V, which are extracted from potatoes and enzymatically modified. Dextrose equivalent seems to be the most important feature influencing immune signaling via activation of TLRs. TLR2 and TLR4 are most strongly stimulated. Especially Paselli WFR is a potent activator of multiple receptors. Moreover, the presence of amylose, even to residual levels, enhances DC and T‐cell cytokine responses. Paselli WFR and Amylose fraction V influence T‐cell polarization.Conclusions: It has been shown here that chain length and particularly dextrose equivalent are critical features for immune activation. This knowledge might lead to tailoring and design of immune‐active RS formulations.

1 January 2021 in Amylase
Verified
Journal Article
Open access
PDF file
GXGang Xiang
Gang Xiang
PBPiet L. Buwalda
Piet L. Buwalda
MMMarc J.E.C van der Maarel
Marc J.E.C van der Maarel
HLHans Leemhuis
Hans Leemhuis
The 4,6-α-glucanotransferases of the glycoside hydrolase family 70 can convert starch into isomaltooligosaccharides (IMOs). However, no thermostable 4,6-α-glucanotransferases have been reported to date, limiting their applicability in the starch conversion industry. Here we report the identification and characterization of a thermostable 4,6-α-glucanotransferase from Bacillus coagulans DSM 1. The gene was cloned and the recombinant protein, called BcGtfC, was produced in Escherichia coli. BcGtfC is stable up to 66 °C in the presence of substrate. It converts debranched starch into an IMO product with a high percentage of α-1,6-glycosidic linkages and a relatively high molecular weight compared to commercially available IMOs. Importantly, the product is only partly and very slowly digested by rat intestine powder, suggesting that the IMO will provide a low glycaemic response in vivo when applied as food ingredient. Thus, BcGtfC is a thermostable 4,6-α-glucanotransferase suitable for the industrial production of slowly digestible IMOs from starch.

13 August 2026 in Molecules
Verified
Journal Article
Open access
PDF file
MEMaurice karel Esse
Maurice karel Esse
HLHans Leemhuis
Hans Leemhuis
JBJohannes Hendrik Bitter
Johannes Hendrik Bitter
Lambertus Van Den BroekLambertus Van Den Broek
Lambertus Van Den Broek
Starch-modifying glycoside hydrolases (GHs) typically operate via a retaining double-displacement mechanism, involving formation of a covalent glycosyl–enzyme intermediate. This intermediate can be resolved either by water, resulting in hydrolysis, or by a glucan acceptor, leading to transglucosylation. Many GHs exhibit both catalytic activities, although they are classified according to their predominant reaction. For example, branching enzymes (BEs) catalyse α-(1→4) bond cleavage and α-(1→6) branch formation via transglucosylation, while also exhibiting minor hydrolytic and disproportionation activities that broaden their catalytic repertoire. More recent research indicates that the different catalytic activities of BEs can be interconnected, thereby collectively determining the final α-glucan architecture. This challenges the classical view that the predominant branching activity of BEs is catalysed independently. Moreover, the balance between these coupled activities influences substrate specificity and can broaden the substrate scope to include chemically modified starches. Furthermore, the co-application of BEs with other GHs reveals synergistic interactions between catalytic activities, enabling the generation of α-glucan structures that cannot be produced by any of the enzymes individually. In this perspective paper, and based on recent developments, we argue that the catalytic framework of BEs provides multiple strategies for tailoring diverse α-glucan architectures. This enables modulation of structural features across hierarchical levels, from supramolecular to macromolecular organisation. As a result, BEs represent versatile tools for engineering starch functionality beyond digestibility, extending their potential toward pharmaceutical and non-food applications. Looking ahead, we discuss how enzyme-designed and chemically functionalised α-glucan polymers may emerge as a new class of sustainable materials. These materials could provide biodegradable, water-soluble, and renewable alternatives to petrochemical-derived polymers used in personal and home care products.